Sage Therapeutics, Inc.
SAGE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $81 | $71 | $163 | $294 |
| Short-Term Investments | $423 | $682 | $1,110 | $1,448 |
| Receivables | $9 | $83 | $14 | $19 |
| Inventory | $0 | $0 | -$64 | $0 |
| Other Curr. Assets | $18 | $33 | $51 | $40 |
| Total Curr. Assets | $531 | $869 | $1,272 | $1,801 |
| Property Plant & Equip (Net) | $12 | $6 | $13 | $19 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $1 | $1 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $4 | $7 | $69 | $4 |
| Total NC Assets | $16 | $13 | $84 | $25 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $547 | $882 | $1,356 | $1,825 |
| Liabilities | – | – | – | – |
| Payables | $13 | $10 | $19 | $10 |
| Short-Term Debt | $1 | $5 | $15 | $15 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $58 | $67 | $65 | $60 |
| Total Curr. Liab. | $72 | $83 | $99 | $85 |
| LT Debt | $11 | $0 | $9 | $22 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | -$4 | -$11 |
| Total NC Liab. | $11 | $0 | $5 | $11 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $12 | $5 | $12 | $18 |
| Total Liabilities | $82 | $83 | $104 | $96 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,970 | -$2,570 | -$2,028 | -$1,495 |
| AOCI | $0 | -$1 | -$10 | -$3 |
| Other Equity | $3,435 | $3,370 | $3,291 | $3,227 |
| Total Equity | $465 | $800 | $1,253 | $1,729 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $547 | $882 | $1,356 | $1,825 |
| Net Debt | -$69 | -$66 | -$138 | -$257 |